5LNF

Solution NMR structure of farnesylated PEX19, C-terminal domain

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCA	1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 750
2	3D HNCACB	1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 750
3	3D CBCA(CO)NH	1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 750
4	3D HCCH-TOCSY	1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 750
5	3D 1H-13C NOESY	1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE 900
6	3D 1H-15N NOESY	1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE 900

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	750
2	Bruker	AVANCE	900

NMR Ensemble Information
Conformer Selection Criteria
Conformers Calculated Total Number
Conformers Submitted Total Number	20

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		BRUNGER A. T. ET.AL.